Frontlight ResearchEarly access
Trial site
Instituto de Diabetes, Obesidad y Nutricion
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Obesity5 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Obstructive sleep apnoea1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company11 trials
- Amgen1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 14 Nov 2026